ADHD in Preschool Age Children (4-5 years old)
Research Study
Eligibility
Your child may be eligible to participate in a clinical research study for ADHD in Preschool Age Children (4-5 years old). This study of an investigational medicine is currently recruiting volunteers in your area. Keep reading to learn more about this trial…
Study Benefits
- No cost for study related treatment
- Investigational medicine is already approved for older ages (i.e., 6 years and older)
- Main study includes 8 in-office visits (placebo controlled)
- Optional extension study includes 12 in-office visits and 8 telephone follow-up visits (all patients receive active treatment)
- Qualified patients may be reimbursed up to $1500 for time & travel
- No insurance is required to participate
If your preschooler…
- Is participating in a structured group activity (e.g., preschool, kindergarten, sports, Sunday school or a childcare program)
-
Is having trouble at school
- Has teachers that have suggested an assessment for ADHD?
Find Out If Your Child May Qualify
Please fill out the form and questionnaire to receive more information about the study. You may be contacted by a study team member*
*You may receive a phone call from one of our offices with either an 812 or 270 area code. Please accept this call to discuss the trial. By filling out the form above, you agree to receive phone calls and/or emails about studies near you. You can unsubscribe from our contact list at any time.
Fill out and submit the form above.
– OR –
Contact our research staff.
Se Habla Español
About the Study
The goal of this study is to evaluate the safety and tolerability of the investigational medicine compared to placebo on ADHD symptoms in preschool-age children (4 to 5 years of age) and diagnosed with ADHD. Your participation in this study will increase the knowledge and understanding of ADHD in preschool-age children. This is a placebo-controlled study with a participation timeline expected to be approximately 8 weeks. An optional long-term extension study lasting an additional 24 months is available. All patients electing to participate in this extension study will receive investigational medicine.
